<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30309377</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>11</Month>            <Day>08</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">0717-6287</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>51</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>11</Day>                    </PubDate>                </JournalIssue>                <Title>Biological research</Title>                <ISOAbbreviation>Biol. Res.</ISOAbbreviation>            </Journal>            <ArticleTitle>Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation.</ArticleTitle>            <Pagination>                <MedlinePgn>39</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s40659-018-0189-0</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">SET domain bifurcated 1 (SETDB1) has been widely considered as an oncogene playing a critical role in many human cancers, including breast cancer. Nevertheless, the molecular mechanism by which SETDB1 regulates breast cancer tumorigenesis is still unknown.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">qRT-PCR assay or western blot analysis was performed to assess the expression level of SETDB1 mRNA or protein, respectively. siSETDB1, pCMV6-XL5-SETDB1, miR-381-3p mimic, or miR-381-3p inhibitor was transfected into cells to regulate the expression of SETDB1 or miR-381-3p. MiRNA directly interacted with SETDB1 was verified by luciferase reporter assay and RNA immunoprecipitation. CCK-8 assay, colony formation assay, flow cytometric analysis, and transwell assay were used to detect the abilities of cell proliferation, cell cycle progression and migration, respectively. Animal model of xenograft tumor was used to observe the regulatory effect of SETDB1 on tumor growth in vivo.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">We verified that SETDB1 mRNA level was upregulated in breast cancer tissues and cell lines, and SETDB1 depletion led to a suppression of cell proliferation, cell cycle progression and migration in vitro, as well as tumor growth in vivo. SETDB1 was verified to be a target of miR-381-3p. Moreover, miR-381-3p overexpression suppressed cell proliferation, cell cycle progression and migration, whereas SETDB1 abated miR-381-3p-mediated regulatory function on breast cancer cells.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study revealed that SETDB1 knockdown might suppress breast cancer progression at least partly by miR-381-3p-related regulation, providing a novel prospect in breast cancer therapy.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Wu</LastName>                    <ForeName>Milu</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, The Affiliated Hospital of Qinghai University, No. 29, Tongren Rd, Xining, 810001, Qinghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fan</LastName>                    <ForeName>Baohua</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, The Affiliated Hospital of Qinghai University, No. 29, Tongren Rd, Xining, 810001, Qinghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Guo</LastName>                    <ForeName>Qijing</ForeName>                    <Initials>Q</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, The Affiliated Hospital of Qinghai University, No. 29, Tongren Rd, Xining, 810001, Qinghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Yan</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, The Affiliated Hospital of Qinghai University, No. 29, Tongren Rd, Xining, 810001, Qinghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chen</LastName>                    <ForeName>Rong</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, The Affiliated Hospital of Qinghai University, No. 29, Tongren Rd, Xining, 810001, Qinghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lv</LastName>                    <ForeName>Nannan</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, The Affiliated Hospital of Qinghai University, No. 29, Tongren Rd, Xining, 810001, Qinghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Diao</LastName>                    <ForeName>Yinzhuo</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, The Affiliated Hospital of Qinghai University, No. 29, Tongren Rd, Xining, 810001, Qinghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Luo</LastName>                    <ForeName>Yushuang</ForeName>                    <Initials>Y</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9678-8004</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, The Affiliated Hospital of Qinghai University, No. 29, Tongren Rd, Xining, 810001, Qinghai, China. shuokunbobo@sina.com.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>81760730</GrantID>                    <Agency>National Natural Science Foundation of China</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>2016-ZJ-785</GrantID>                    <Agency>Scientific Research Project Funds of Qinghai Department</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>11</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Biol Res</MedlineTA>            <NlmUniqueID>9308271</NlmUniqueID>            <ISSNLinking>0716-9760</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C588249">MIRN381 microRNA, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.1.1.-</RegistryNumber>                <NameOfSubstance UI="D011496">Protein Methyltransferases</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.1.1.-</RegistryNumber>                <NameOfSubstance UI="C454062">SETDB1 protein, human</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell. 2004 Aug 27;15(4):595-605</RefSource>                <PMID Version="1">15327775</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Methods Mol Biol. 2015;1296:187-98</RefSource>                <PMID Version="1">25791601</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tumour Biol. 2016 Jun;37(6):7245-54</RefSource>                <PMID Version="1">26666820</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2011 Aug 05;11(9):644-56</RefSource>                <PMID Version="1">21822212</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2014 Dec 15;74(24):7333-43</RefSource>                <PMID Version="1">25477335</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hepatology. 2016 Feb;63(2):474-87</RefSource>                <PMID Version="1">26481868</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Exp Dermatol. 2014 May;23(5):332-8</RefSource>                <PMID Version="1">24673285</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2010 Apr 8;464(7290):927-31</RefSource>                <PMID Version="1">20164836</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Amino Acids. 2011 Jul;41(2):387-99</RefSource>                <PMID Version="1">20617350</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2005 Feb 17;433(7027):769-73</RefSource>                <PMID Version="1">15685193</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2007 Oct 11;449(7163):682-8</RefSource>                <PMID Version="1">17898713</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2007 Dec 14;131(6):1109-23</RefSource>                <PMID Version="1">18083101</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2008 Jan 10;451(7175):147-52</RefSource>                <PMID Version="1">18185580</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2014 Feb 6;33(6):679-89</RefSource>                <PMID Version="1">23353819</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2015 Apr 1;75(7):1433-44</RefSource>                <PMID Version="1">25634212</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Genet. 2009 Oct;10(10):704-14</RefSource>                <PMID Version="1">19763153</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mol Biol. 2010 Sep 24;402(3):491-509</RefSource>                <PMID Version="1">20678503</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2016 Jan 28;35(4):448-58</RefSource>                <PMID Version="1">25867061</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62</RefSource>                <PMID Version="1">24114568</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Stem Cells. 2014 Nov;32(11):2858-68</RefSource>                <PMID Version="1">25070049</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Invest. 2012 Sep;122(9):3248-59</RefSource>                <PMID Version="1">22863622</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Cancer Res. 2017 Apr 01;7(4):913-922</RefSource>                <PMID Version="1">28469963</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomed Pharmacother. 2017 Feb;86:426-433</RefSource>                <PMID Version="1">28012397</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2008 Apr 30;3(4):e2037</RefSource>                <PMID Version="1">18446223</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Commun. 2015 Oct 16;6:8651</RefSource>                <PMID Version="1">26471002</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2014 May 22;33(21):2807-13</RefSource>                <PMID Version="1">23770855</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuromolecular Med. 2014 Mar;16(1):70-82</RefSource>                <PMID Version="1">23943221</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomed Pharmacother. 2018 Feb;98:538-544</RefSource>                <PMID Version="1">29287202</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Biol. 2006 Nov;26(21):8191-201</RefSource>                <PMID Version="1">16940181</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2011 Mar 24;471(7339):513-7</RefSource>                <PMID Version="1">21430779</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2005 Aug 15;65(16):7065-70</RefSource>                <PMID Version="1">16103053</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2006 Jul 14;281(28):19489-500</RefSource>                <PMID Version="1">16682412</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Mol Cell Biol. 2005 Nov;6(11):838-49</RefSource>                <PMID Version="1">16261189</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Stem Cell. 2011 Jun 3;8(6):676-87</RefSource>                <PMID Version="1">21624812</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Oncol. 2012 Sep;41(3):869-75</RefSource>                <PMID Version="1">22752005</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Biol. 2005 Dec 6;15(23):2149-55</RefSource>                <PMID Version="1">16289642</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2016 Jul;66(4):271-89</RefSource>                <PMID Version="1">27253694</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian J Androl. 2014 Mar-Apr;16(2):319-24</RefSource>                <PMID Version="1">24556744</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011496" MajorTopicYN="N">Protein Methyltransferases</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Cell cycle progression</Keyword>            <Keyword MajorTopicYN="N">Migration</Keyword>            <Keyword MajorTopicYN="N">Proliferation</Keyword>            <Keyword MajorTopicYN="N">SET domain bifurcated 1</Keyword>            <Keyword MajorTopicYN="N">miR-381-3p</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>07</Month>                <Day>13</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>9</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30309377</ArticleId>            <ArticleId IdType="doi">10.1186/s40659-018-0189-0</ArticleId>            <ArticleId IdType="pii">10.1186/s40659-018-0189-0</ArticleId>            <ArticleId IdType="pmc">PMC6180515</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>